14 | $SPRC 64% v22,6M C5.62 f523,778 Hod6.64 | znewcar1 | 10/31/2023 10:52:24 PM |
13 | $SPRC 38% v13,2M C5.10 f521,090 Hod7.0499 | znewcar1 | 10/03/2023 4:22:01 PM |
11 | $SPRC 32% v196M C.2074 f12,898M Hod.3657 ML.1407 | znewcar1 | 09/27/2023 5:52:42 PM |
10 | $SPRC 23% v3,3M c.83 f7,220M H.87 ML.5027 | znewcar1 | 06/01/2023 10:08:28 PM |
9 | $SPRC Press release- SciSparc Makes Another Step | mojostocks | 05/30/2023 12:11:03 PM |
8 | SPRC 23% V91,5m C.965 F3,5m h1.45 | znewcar1 | 09/14/2022 6:15:19 PM |
7 | SPRC 19% v66,8M c1.115 f3,5M H1.55 | znewcar1 | 08/24/2022 11:07:30 PM |
6 | SPRC 41% v26M c3.33 f3,2M H3.750 preMH4.65 | znewcar1 | 05/26/2022 4:09:34 PM |
5 | SPRC 42% v15,4M c2.8 f3,2M H3.95 | znewcar1 | 05/24/2022 5:09:07 PM |
4 | SciSparc Exploring Psychedelics as Possible | Lee Adams | 01/11/2022 10:23:19 AM |
3 | SciSparc Announces Recruitment of First Patient | Lee Adams | 01/06/2022 10:46:58 AM |
2 | SciSparc Issued U.S. Patent For Its Core | Lee Adams | 01/04/2022 9:24:53 AM |
1 | SciSparc Provides Updates Upon Conclusion of 2021 | Lee Adams | 01/03/2022 10:02:42 AM |
Recent Articles
- Breakthrough Outcomes of Telitacicept in Sjögren's Syndrome Study
- Republic Power Group's Initial Public Offering Unveiled
- Publicis Groupe Shows Impressive 5.7% Organic Growth in Q3 2025
- Serabi Gold Celebrates Record Production of Gold Ounces
- Publicis Groupe Reports Impressive Third Quarter Growth
- Ericsson and Vodafone Unveil Ambitious Network Partnership
- Transforming Connectivity: Ericsson and Vodafone's Bold Partnership
- ASUS Launches Revolutionary AI Solutions for Enterprises
- Moomoo Emerges as Australia's Leading Trading App in Downloads
- Leqembi Iqlik Recognized as a Leading Innovation of 2025
- Leqembi Iqlik™ Recognized as a Top Medical Innovation of 2025
- Arcadis Shares Buyback Initiatives Drive Corporate Strategy
- WISeKey Reports Strong Revenue Growth and Future Prospects
- DNO ASA's Q3 2025 Update: Production and Financial Insights
- dsm-firmenich Sees Steady Progress in Share Buyback Program
- Memecoin Surge: Shiba Inu and Pepe Lead the Charge
- ASUS Leads in AI Solutions with Innovative NVIDIA Technologies
- DHT Holdings, Inc. Provides Insight into Financial Progress
- How the Crypto Market is Impacting Gold Prices Today
- Apple's iPhone Air Preorders Begin as eSIM Services Launch
- Lodha's Recognition as a Trusted Company Escalates Its Prestige
- Lodha's Achievement in Global Trust Recognition Highlights Values
- Howard Marks Analyzes Current Market Valuations and Trends
- ADI Foundation's Bold Mission: Bridging Global Digital Gaps
- BenQ's New Monitors Enhance Creativity for Mac Users
- U.S. Lumber Coalition Celebrates Trade Law Enforcement Gains
- Airties Launches Nova: A New Era for Connectivity Testing
- Dr. James Petros Unveils OrthoGen Health: A New Era in Healing
- Marketing Maven Secures Spot Among Nation's Elite PR Agencies
- Vacca Family Law Group Enhances Support for Peaceful Divorce
- Dow Inc. Investors Urged to Act in Upcoming Securities Case
- Adlai Nortye to Showcase Innovative Cancer Therapy at Key Conference
- Understanding Shareholder Rights and Legal Options for Investors
- Investigation Into Shareholder Rights for Companies in Transition
- Adlai Nortye's Pioneering Cancer Therapy Presentation at Key Conference
- How Google's AI Insights Are Shaping the Future of Search
- GOL Linhas Aéreas Merges with Gol Investment Brasil for Growth
- Market Update: Ethereum and XRP Shine While Bitcoin Consolidates
- Steve Eisman Highlights Growing Economic Disconnect in America
- CoHNA Celebrates Governor's Decision Against SB509 Bill
- Forecasting Growth of Anesthesia Management Systems Until 2034
- Valuable Life Lessons From Donald Trump to His Granddaughter
- GIGABYTE Unveils Global Availability of AI TOP ATOM Supercomputer
- ASUS Unveils the Game-Changing Ascent GX10 AI Supercomputer
- Apollomics, Inc. Embraces New Leadership to Advance Oncology
- Spyre Therapeutics Focuses on $275 Million Common Stock Offering
- Spyre Therapeutics Secures Funding for Advanced Therapeutics
- Take Action: Join the Quanex Building Products Class Action
- Jasper Therapeutics Investors Invited to Join Class Action Suit
- Cytokinetics, Inc. Investors: Important Class Action Alert